Skip to main content

Dacogen Side Effects

Generic name: decitabine

Medically reviewed by Drugs.com. Last updated on Jan 5, 2024.

Note: This document contains side effect information about decitabine. Some dosage forms listed on this page may not apply to the brand name Dacogen.

Applies to decitabine: intravenous powder for solution.

Serious side effects of Dacogen

Along with its needed effects, decitabine (the active ingredient contained in Dacogen) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking decitabine:

More common

Less common

Incidence not known

Other side effects of Dacogen

Some side effects of decitabine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to decitabine: intravenous powder for injection.

Hematologic

Very common (10% or more): Neutropenia (90%), thrombocytopenia (89%), anemia (68%), febrile neutropenia (29%), leukopenia (28%), lymphadenopathy (12%)

Common (1% to 10%): Thrombocythemia

Uncommon (0.1% to 1%): Pancytopenia[Ref]

Gastrointestinal

Very common (10% or more): Nausea (42%), constipation (35%), diarrhea (34%), vomiting (25%), abdominal pain (14%), oral mucosal petechiae (13%), stomatitis (12%), dyspepsia (12%), ascites (10%)

Common (1% to 10%): Gingival bleeding, hemorrhoids, loose stools, tongue ulceration, dysphagia, oral soft tissue disorder, lip ulceration, abdominal distension, upper abdominal pain, gastroesophageal reflux disease, glossodynia

Frequency not reported: Enterocolitis (including neutropenic colitis, cecitis)[Ref]

Respiratory

Very common (10% or more): Cough (40%), pneumonia (24%), pharyngitis (16%), epistaxis (14%), lung crackles (14%), breath sounds decreased (10%), hypoxia (10%)

Common (1% to 10%): Sinusitis, rales, postnasal drip

Frequency not reported: Interstitial lung disease[Ref]

Other

Very common (10% or more): Pyrexia (53%), peripheral edema (25%), rigors (22%), edema (18%), pain (13%), lethargy (12%), tenderness (11%), blood alkaline phosphatase increased (11%), blood urea increased (10%)

Common (1% to 10%): Fall, chest wall pain, intermittent pyrexia, malaise, crepitations, blood lactate dehydrogenase increased, blood albumin decreased, blood bicarbonate increased, blood chloride decreased, decreased total protein, blood bilirubin decreased[Ref]

Metabolic

Very common (10% or more): Hyperglycemia (33%), hypoalbuminemia (24%), hypomagnesemia (24%), hypokalemia (22%), hyponatremia (19%), appetite decreased (16%), anorexia (16%), hyperkalemia (13%)

Common (1% to 10%): Dehydration[Ref]

Nervous system

Very common (10% or more): Headache (28%), dizziness (18%), hypoesthesia (11%)[Ref]

Psychiatric

Very common (10% or more): Insomnia (28%), confusion (12%), anxiety (11%)[Ref]

Immunologic

Very common (10% or more): Bacterial, viral, fungal infections (63%), candida infection (10%)

Common (1% to 10%): Septic shock, sepsis, staphylococcal infection, oral candidiasis, bacteremia[Ref]

Dermatologic

Very common (10% or more): Ecchymosis (22%), rash (19%), erythema (14%), cellulitis (12%) skin lesion (11%), pruritus (11%)

Common (1% to 10%): Alopecia, urticaria, swelling face

Uncommon (0.1% to 1%): Acute febrile neutrophilic dermatosis (Sweet's syndrome)[Ref]

Musculoskeletal

Very common (10% or more): Arthralgia (20%), pain in limb (19%), back pain (17%)

Common (1% to 10%): Chest wall pain, musculoskeletal discomfort, myalgia[Ref]

Cardiovascular

Very common (10% or more): Petechiae (39%), pallor (23%), cardiac murmur (16%)

Common (1% to 10%): Pulmonary edema, hypotension, hematoma[Ref]

Hepatic

Very common (10% or more): Hyperbilirubinemia (14%)[Ref]

Hypersensitivity

Common (1% to 10%): Hypersensitivity including anaphylaxis[Ref]

Ocular

Common (1% to 10%): Blurred vision[Ref]

Genitourinary

Very common (10% or more): Urinary tract infection (15%)

Common (1% to 10%): Dysuria, urinary frequency

.[Ref]

Local

Common (1% to 10%): Injection site erythema, injection site pain, injection site swelling[Ref]

References

1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Product Information. Decitabine (decitabine). Accord Healthcare Inc. 2017.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.